Added to YB: 2025-11-19
Pitch date: 2025-11-17
NPTH.V [neutral]
NeuPath Health Inc.
+30%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.
Market Cap
CAD 23.5M
Pitch Price
CAD 0.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.03
P/E
-42.33
EV/Sales
0.39
Sector
Health Care Providers and Services
Category
growth
Catalyst Watch - NeuPath Health Inc. (NPTH.V) | Health Care Services
NPTH.V (earnings): Q3 2025 revenue +26% YOY to $22.1M, adj EBITDA +98% to $1.5M. Strong patient visit growth, rising Arthrosamid demand. Optimized facility footprint & improved medical staffing driving cash flow gains. Expects continued organic/M&A growth.
Read full article (1 min)